# Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer

> **NCT03532711** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 264 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Chemotherapy Effect
- Biomarker

## Interventions

- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT03532711
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2016-12-31
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532711, "Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03532711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*